The Effect of Mitral Stenosis on Maternal and Fetal Outcome in

Objectives: The aim of the study was evaluate maternal and fetal outcomes of mitral stenosis at pregnant women. Methods: Forty-one pregnant woman with moderate and severe mitral stenosis were enrolled in the study. Predictor variables were the apgar score, new born weight and delivery week. Progression of NYHA functional class, thromboembolism, death, new onset atrial fibrillation was accepted as maternal event. Abortion, fetal or neonatal death, prematurity or low birth weight were accepted as fetal events. Results: In newborn babies, 10 were followed-up in intensive care. The mothers of these infants had higher LA diameters, their MVA’s were smaller and the pulmonary hypertension was higher.It was observed that the LA diameter and warfarin treatment were independent risk factors for the need for intensive care. The NYHA was primarily dependent from the LA diameter, followed by the MVA, mean difference in the pressure and the pulmonary artery pressure (PAP).The independent risk factors of the birth weight and the 1st min. and 5th min. Apgar scores, only the LA diameter was found as significant. Also, the independent risk factors of the gestational age at birth are the NYHA classification and the MVA. Warfarin treatment in the mother has also been observed as a risk factor for IUGR. Conclusion: These results reveal that especially patients with mitral stenosis should be closelymonitored

[1]  Blase A. Carabello,et al.  Valvular heart disease. , 2019, The New England journal of medicine.

[2]  A. Firouzi,et al.  Immediate Results of Percutaneous Trans-Luminal Mitral Commissurotomy in Pregnant Women with Severe Mitral Stenosis , 2012, Clinical Medicine Insights. Cardiology.

[3]  David M. Williams,et al.  2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame , 2010, Journal of the American College of Cardiology.

[4]  C. Bonanno,et al.  Mechanisms of hemostasis at cesarean delivery. , 2008, Clinics in perinatology.

[5]  A. V. Van Zundert,et al.  Anesthesia for pregnant women with valvular heart disease: the state-of-the-art , 2007, Journal of Anesthesia.

[6]  A. Kriplani,et al.  Cardiac disease in pregnancy , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[7]  V. Suri,et al.  Maternal and perinatal outcome in rheumatic heart disease , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[8]  Adil A M Al-Lawati,et al.  Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  U. Elkayam,et al.  The effect of valvular heart disease on maternal and fetal outcome of pregnancy. , 2001, Journal of the American College of Cardiology.

[10]  I. Kleinschmidt,et al.  Mitral stenosis in pregnancy: a four‐year experience at King Edward VIII Hospital, Durban, South Africa , 2000, BJOG : an international journal of obstetrics and gynaecology.

[11]  U. Elkayam,et al.  Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. , 1997, The American journal of cardiology.

[12]  U. Elkayam,et al.  Cardiovascular Problems in Pregnant Women with the Marfan Syndrome , 1995, Annals of Internal Medicine.

[13]  M. Dolgin,et al.  Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels , 1994 .

[14]  L. Magee,et al.  Congenital aortic stenosis and pregnancy--a reappraisal. , 1993, American journal of obstetrics and gynecology.

[15]  M. Brodsky,et al.  New-onset ventricular tachycardia during pregnancy. , 1992, American heart journal.

[16]  S. Rahimtoola,et al.  WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias. , 1992, American heart journal.

[17]  K. Tahvanainen,et al.  Acute effects of dihydralazine mesylate, furosemide, and metoprolol on maternal hemodynamics in pregnancy‐induced hypertension , 1987, American journal of obstetrics and gynecology.

[18]  M. Lindheimer,et al.  Plasma catecholamine responses to physiologic stimuli in normal human pregnancy. , 1986, American journal of obstetrics and gynecology.

[19]  A. Pääkkönen,et al.  Acute effects of dihydralazine mesylate, furosemide, and metoprolol on maternal hemodynamics in pregnancy-induced hypertension☆☆☆ , 1986 .

[20]  S. Clark,et al.  Labor and delivery in the presence of mitral stenosis: central hemodynamic observations. , 1985, American journal of obstetrics and gynecology.

[21]  J. Pearson,et al.  Influence of digitalis on time of onset and duration of labour in women with cardiac disease. , 1974, British medical journal.

[22]  P. Szekely,et al.  Pregnancy and the changing pattern of rheumatic heart disease. , 1973, British heart journal.

[23]  J. Madden,et al.  The effect of thiazide diuretics on placental function. , 1973, Texas medicine.

[24]  Jeroen J. Bax,et al.  ESC Guidelines on the management of cardiovascular diseases during pregnancy , 2011 .

[25]  Ella A. Kazerooni,et al.  Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease , 2010 .

[26]  Helmut Baumgartner,et al.  Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .

[27]  J. Willerson,et al.  Pregnancy and the Heart , 2007 .

[28]  R. Page,et al.  Procainamide administration during pregnancy. , 1993, Clinical pharmacy.